Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Iloprost Injection, for intravenous use
DRUG
2 trials
Sponsors
Civi Biopharma, Inc.
Conditions
Raynaud Phenomenon Secondary to Systemic Sclerosis
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Phase 2
Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)
Completed
NCT03867097
Civi Biopharma, Inc.
Raynaud Phenomenon Secondary to Systemic Sclerosis
Start: 2019-03-07
End: 2019-08-06
Updated: 2025-05-25
Phase 3
Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)
Completed
NCT04040322
Civi Biopharma, Inc.
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Start: 2019-10-14
End: 2021-06-09
Updated: 2025-05-25